Tada Y - Search Results

1

Selective targeting of KRAS-driven lung tumorigenesis via unresolved ER stress.

Shimomura I, Watanabe N, Yamamoto T, Kumazaki M, Tada Y, Tatsumi K, Ochiya T, Yamamoto Y. Shimomura I, et al. Among authors: tada y. JCI Insight. 2021 Apr 8;6(7):e137876. doi: 10.1172/jci.insight.137876. JCI Insight. 2021. PMID: 33830081 Free PMC article.

2

T cell dependent and independent antitumor immunity generated by the expression of Fas ligand on mouse lung carcinoma cells.

Tada Y, O-Wang J, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Tada Y, et al. Int J Mol Med. 2002 Mar;9(3):281-5. Int J Mol Med. 2002. PMID: 11836634

3

Expression of the TNF-alpha gene on mouse lung carcinoma cells suppresses spontaneous lung metastasis without affecting tumorigenicity.

Tada Y, O-Wang J, Takenaga K, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Tada Y, et al. Oncol Rep. 2002 May-Jun;9(3):585-8. Oncol Rep. 2002. PMID: 11956632

4

Antitumor effects are produced by forced expression of membrane-bound but not soluble Fas ligand in murine lung carcinoma cells.

Tada Y, O-Wang J, Seimiya M, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Tada Y, et al. Anticancer Res. 2002 Mar-Apr;22(2A):831-6. Anticancer Res. 2002. PMID: 12014659

5

Cutting edge: a novel role for Fas ligand in facilitating antigen acquisition by dendritic cells.

Tada Y, O-Wang J, Takiguchi Y, Tatsumi K, Kuriyama T, Okada S, Tokuhisa T, Sakiyama S, Tagawa M. Tada Y, et al. J Immunol. 2002 Sep 1;169(5):2241-5. doi: 10.4049/jimmunol.169.5.2241. J Immunol. 2002. PMID: 12193688

6

Fas ligand-expressing tumors induce tumor-specific protective immunity in the inoculated hosts but vaccination with the apoptotic tumors suppresses antitumor immunity.

Tada Y, O-Wang J, Wada A, Takiguchi Y, Tatsumi K, Kuriyama T, Sakiyama S, Tagawa M. Tada Y, et al. Cancer Gene Ther. 2003 Feb;10(2):134-40. doi: 10.1038/sj.cgt.7700545. Cancer Gene Ther. 2003. PMID: 12536202

7

T-cell-dependent antitumor effects produced by CD40 ligand expressed on mouse lung carcinoma cells are linked with the maturation of dendritic cells and secretion of a variety of cytokines.

Tada Y, O-Wang J, Yu L, Shimozato O, Wang YQ, Takiguchi Y, Tatsumi K, Kuriyama T, Takenaga K, Sakiyama S, Tagawa M. Tada Y, et al. Cancer Gene Ther. 2003 Jun;10(6):451-6. doi: 10.1038/sj.cgt.7700584. Cancer Gene Ther. 2003. PMID: 12768190

8

Expression of CD40 ligand in CD40-positive murine tumors activates transcription of the interleukin-23 subunit genes and produces antitumor responses.

Wada A, Tada Y, Shimozato O, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Wada A, et al. Among authors: tada y. Anticancer Res. 2004 Sep-Oct;24(5A):2713-6. Anticancer Res. 2004. PMID: 15517876 Free article.

9

Vaccination of apoptotic Fas ligand-expressing tumors decreased antitumor responses by enhanced production of immunosuppressive cytokines.

Wada A, Tada Y, Shimozato O, Takiguchi Y, Tatsumi K, Kuriyama T, Tagawa M. Wada A, et al. Among authors: tada y. Anticancer Res. 2005 Jan-Feb;25(1A):299-303. Anticancer Res. 2005. PMID: 15816551 Free article.

10

The effects of FasL on inflammation and tumor survival are dependent on its expression levels.

Wada A, Tada Y, Kawamura K, Takiguchi Y, Tatsumi K, Kuriyama T, Takenouchi T, O-Wang J, Tagawa M. Wada A, et al. Among authors: tada y. Cancer Gene Ther. 2007 Mar;14(3):262-7. doi: 10.1038/sj.cgt.7701008. Epub 2006 Oct 20. Cancer Gene Ther. 2007. PMID: 17053813

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

1,632 results

Search Page

Filters